Efficacy of Clarithromycin Treatment in Prevention of Chronic Lung Disease in Premature Infants

• Status: Completed
• Trial end date: 2010-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the efficacy of clarithromycin in eradication of ureaplasma urealyticum and prevention of chronic lung disease in premature infants with birthweight < 1250 g and have ureaplasma urealyticum colonization.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Zekai Tahir Burak Women's Health Research and Education Hospital
• Treatments: Clarithromycin

Criteria

Inclusion Criteria:

• The babies under 1250 gram

• The babies must be appropriate for gestational age

Exclusion Criteria:

• Multiple congenital anomalies or known syndromes

• Intrauterine growth retardation with birthweight less than 10 percentile for gestational age